Newborn screening fees set; core testing delayed

Summary#

HB 1625, Public Health – Newborn Screening Program – Fees and Core Conditions, would amend Maryland’s Health-General Article; it does not create a new law or agency. Its stated goal is to change how the state sets newborn-screening fees and decides whether to add new core conditions to screening.

  • The Department of Health would have to set screening fees at an amount not less than what is sufficient to cover administrative, laboratory, and follow-up costs.
  • When a condition is added to the federal Recommended Uniform Screening Panel, the State Advisory Council on Hereditary and Congenital Disorders would have to advise the Department about the risks, harms, accessibility, and costs of testing, and recommend whether Maryland should implement it.
  • After considering that advice, the Department could implement testing, delay it, or decide not to implement it. The bill removes the existing 18-month implementation requirement for newly added core conditions.
  • The Department would have to report to legislative committees if it decides not to test for a new core condition, delays testing for more than two years, or cannot meet the two-year deadline because of equipment or supply procurement delays.
  • The bill retains the existing newborn-screening system, including the rule that parents or guardians may object to screening. The supplied bill text says it would take effect June 1, 2026, if enacted; the supplied status says it has passed the House, so it is not yet law.

What it means for you#

  • Parents and guardians: The bill does not remove the option to object to newborn screening. It could mean that a condition added to the federal panel is not tested for in Maryland, or that testing is delayed, if the Department chooses that course.
  • Newborns and health care providers: The existing screening system and follow-up duties remain. The bill does not set a deadline for the Department to decide whether to add testing for a newly listed condition.
  • People who pay newborn-screening fees: The fee amount would have to meet or exceed the amount sufficient to cover specified program costs. The bill does not identify who pays the fees or set a dollar amount.

Money#

The bill sets a fee floor tied to specified program costs, but no dollar estimate is supplied.

  • The fees must be sufficient to cover administrative, laboratory, and follow-up costs; the bill does not cap them at that level.
  • The bill retains the existing direction that collected fees go to the Newborn Screening Program Fund.
  • No publicly available information in the supplied materials gives an estimate of added staffing, reporting, or other costs.

What is unclear#

  • The supplied text shows both “May 31” and “January 1, 2026” for the date used to identify core conditions Maryland must screen for. The exact date cannot be established from this text.
  • The bill does not say who pays the fees, how they are billed, or how the Department would calculate the amount sufficient to cover costs.
  • It does not set a deadline for the Council’s advice or the Department’s decision about a newly added condition.
  • The bill does not specify how the Department should weigh the Council’s advice, or what process applies to a decision not to test.
  • The supplied material does not include the full current Act, so the existing-law comparison cannot be independently checked beyond the changes shown in the bill text.

Case for#

  • The Council would have to consider risks, harms, accessibility, and costs before the Department decides whether to add testing. That could support decisions that take both potential benefits and practical limits into account.
  • Giving the Department the option to delay or decline testing could let it respond to concerns about cost, access, or readiness rather than follow an automatic deadline.
  • Required reports could give legislators reasons and timelines when testing is not implemented or is delayed.

Case against#

  • The Department could decide not to test for a federally listed core condition, and the bill does not require it to follow the Council’s recommendation.
  • The bill removes the 18-month implementation requirement without setting a deadline for deciding whether to test. Some conditions could therefore go untested or face an extended delay.
  • Requiring fees to be at least sufficient to cover specified costs could mean higher fees, but the bill does not identify who would bear them or limit the amount.

Votes

The recorded vote on this bill, member by member.

  1. Division No. 1672408

    Passed135 members voted

    Third Reading Passed

    FOR · 121AGAINST · 14

    121For

    • Democratic99
    • Republican22

    14Against

    • Republican14

    6 members were paired and sat out the vote.